Rosetta Genomics Ltd. (ROSGQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Mar 3, 2026
Rosetta Genomics Revenue
Rosetta Genomics had revenue of $870.00K in the quarter ending June 30, 2017, with 115.35% growth. This brings the company's revenue in the last twelve months to $2.86M, up 106.43% year-over-year. In the year 2016, Rosetta Genomics had annual revenue of $2.04M, down -29.08%.
Revenue (ttm)
2.86M
Revenue Growth
+106.43%
P/S Ratio
0.00
Revenue / Employee
33.24K
Employees
86
Market Cap
593.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2016 | 2.04M | -836.00K | -29.08% |
| Dec 31, 2015 | 2.88M | 1.55M | 116.65% |
| Dec 31, 2014 | 1.33M | 922.00K | 227.65% |
| Dec 31, 2013 | 405.00K | 204.00K | 101.49% |
| Dec 31, 2012 | 201.00K | 98.00K | 95.15% |
| Dec 31, 2011 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
| Dec 31, 2009 | Pro | Pro | Pro |
| Dec 31, 2008 | Pro | Pro | Pro |
| Dec 31, 2007 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Arrayit | 2.82M |
| Biocept | 1.36M |
| HTG Molecular Diagnostics | 6.21M |
| Todos Medical | 10.75M |
| Response Genetics | 16.62M |
| Cyclo3pss | 366.01K |
| Integrative Health Technologies | 447.50K |
| RushNet | 6.90M |